Rigel Pharmaceuticals
RIGL
RIGL
90 hedge funds and large institutions have $85.4M invested in Rigel Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 39 increasing their positions, 24 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
48% less capital invested
Capital invested by funds: $164M → $85.4M (-$78.9M)
67% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 39
Holders
90
Holding in Top 10
1
Calls
$4.28M
Puts
$3.68M
Top Buyers
| 1 | +$1.65M | |
| 2 | +$982K | |
| 3 | +$832K | |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$739K |
| 5 |
AC
Armistice Capital
New York
|
+$723K |
Top Sellers
| 1 | -$4.77M | |
| 2 | -$2.96M | |
| 3 | -$2.95M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$2.37M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.23M |